Most kidney cancer is not hereditary, but some families carry genetic changes that raise the risk

About 90 percent of kidney cancers occur in people with no family history of the disease. However, certain inherited genetic conditions do increase the chance that a person will develop kidney cancer during their lifetime. If you have a close relative with kidney cancer, or if kidney cancer appears in multiple family members across generations, your own risk may be higher than average.

Understanding which genetic syndromes carry this risk, and what screening might look like, can help you make informed decisions about your health. This information is meant to help you have a more informed conversation with your doctor, not to predict whether you will develop kidney cancer.

Key Takeaways

  • Most kidney cancers are not inherited, but several genetic syndromes—including Von Hippel-Lindau disease, hereditary papillary renal carcinoma, and Birt-Hogg-Dubé syndrome—do increase kidney cancer risk across family members.
  • If multiple close relatives have had kidney cancer, or if kidney cancer appeared before age 50, genetic testing may help identify whether a hereditary syndrome runs in your family.
  • People who carry genes for hereditary kidney cancer syndromes often benefit from regular imaging (usually ultrasound or CT scans) starting in early adulthood to catch tumors early.
  • A genetic counselor can explain your personal and family risk, discuss whether testing makes sense for you, and help you understand what results would mean for your health decisions.

The main hereditary syndromes linked to kidney cancer

Von Hippel-Lindau disease (VHL) is the most common hereditary kidney cancer syndrome. People who inherit a mutated VHL gene have a 70 to 80 percent lifetime risk of developing kidney cancer, often in both kidneys and sometimes at a younger age than sporadic cases. VHL also raises the risk of cysts and tumors in other organs, including the pancreas, adrenal glands, and central nervous system.

Hereditary papillary renal carcinoma (HPRC) is caused by mutations in the MET gene. People with this syndrome typically develop multiple kidney tumors, often in both kidneys, usually starting in middle age. The tumors tend to grow more slowly than other types of kidney cancer.

Birt-Hogg-Dubé syndrome (BHD) results from mutations in the FLCN gene. It causes kidney tumors in about 20 to 30 percent of people who carry the mutation, along with benign skin growths and lung cysts. Kidney cancers in BHD tend to occur in the 40s and 50s.

Hereditary renal oncocytoma is a rare syndrome in which people develop multiple benign tumors (oncocytomas) in the kidneys. While these are usually not cancerous, they require monitoring to watch for any changes over time.

When to consider genetic testing

Genetic testing for hereditary kidney cancer syndromes is most useful when certain patterns appear in your family or personal history. You may want to discuss testing with your doctor if you have been diagnosed with kidney cancer before age 50, if you have kidney cancer in both kidneys, if multiple close relatives (parent, sibling, child) have had kidney cancer, or if you have a known family history of one of the hereditary syndromes.

Testing typically begins with a conversation with a genetic counselor or your oncologist. They will review your family tree, discuss your personal medical history, and explain what testing can and cannot tell you. If testing seems appropriate, a blood or saliva sample is sent to a laboratory that looks for mutations in the genes associated with hereditary kidney cancer syndromes. Results usually take two to four weeks to return.

A positive result means you carry a mutation linked to increased kidney cancer risk. A negative result suggests you do not carry the specific mutation being tested for, though it does not rule out all hereditary causes. Your doctor will discuss what the results mean for your health and whether any follow-up testing or screening is recommended.

What screening looks like if you carry a hereditary mutation

If genetic testing shows you carry a mutation for a hereditary kidney cancer syndrome, your doctor will typically recommend regular imaging to watch for tumors. For Von Hippel-Lindau disease, screening usually starts in childhood or early adulthood and involves ultrasound or CT scans of the abdomen every one to two years. For other syndromes, screening schedules vary based on the specific condition and your age.

The goal of regular screening is to find tumors when they are small and before they cause symptoms. Small tumors caught early often have better treatment outcomes and may allow for kidney-sparing surgery, which preserves as much kidney function as possible. Your doctor will discuss the timing and type of imaging that makes sense for your specific situation.

Screening also typically includes monitoring other organs that may be affected by the hereditary syndrome. For example, people with Von Hippel-Lindau disease may need screening for pancreatic cysts, adrenal tumors, and central nervous system hemangioblastomas. Your doctor will create a personalized screening plan based on which syndrome you carry.

How to talk with family members about hereditary risk

If genetic testing shows you carry a hereditary kidney cancer mutation, your blood relatives may also carry the same mutation. Some families find it helpful to share this information with close relatives so they can make informed decisions about their own screening and testing. However, there is no obligation to tell family members, and the decision is personal.

If you do decide to share the information, a genetic counselor can help you prepare for the conversation and provide written materials to give to relatives. Many relatives appreciate knowing about the risk so they can discuss testing and screening options with their own doctors. Some may choose testing; others may prefer to wait or decline it altogether. A genetic counselor can also help you think through how to frame the conversation in a way that feels right for your family.

Living with hereditary kidney cancer risk

Carrying a gene mutation for a hereditary kidney cancer syndrome does not mean you will definitely develop kidney cancer, even though the risk is higher than in the general population. Many people with these mutations live long, healthy lives, especially when tumors are caught early through screening.

Regular follow-up appointments with your doctor, adherence to the recommended screening schedule, and open communication about any new symptoms or concerns are important parts of managing your health. Some people also find it helpful to connect with others who have the same hereditary syndrome, either through support groups or online communities, to share experiences and practical advice. Your doctor or genetic counselor can point you toward resources specific to your condition.

Frequently Asked Questions

If my parent had kidney cancer, will I definitely get it too?

Not necessarily. Even if your parent had hereditary kidney cancer, you have a 50 percent chance of inheriting the same mutation (if the cancer was hereditary). And inheriting the mutation does not may provide you will develop kidney cancer—it only raises your risk. Genetic testing and talking with a genetic counselor can clarify your actual risk based on your family's specific situation.

Can I get genetic testing through my regular doctor?

Your regular doctor can order genetic testing and refer you to a genetic counselor, but the test itself is usually performed at a specialized laboratory. Many insurance plans cover genetic testing and counseling when there is a family history of kidney cancer or a personal diagnosis before age 50. Your doctor's office can check your coverage and help arrange the referral.

What does it mean if genetic testing is negative?

A negative result means you did not inherit the specific mutation being tested for. However, it does not completely rule out hereditary kidney cancer risk, since not all hereditary syndromes are fully understood. If you have a strong family history, your doctor may still recommend screening or periodic follow-up conversations as new genetic knowledge emerges.

How often do I need imaging if I carry a hereditary mutation?

Screening frequency depends on which syndrome you carry and your age. For Von Hippel-Lindau disease, imaging typically happens every one to two years starting in childhood or early adulthood. For other syndromes, screening may begin later or happen less frequently. Your doctor will create a personalized screening plan based on your specific condition and risk factors.

Can kidney cancer from a hereditary syndrome be treated differently?

Treatment options—surgery, targeted therapy, immunotherapy, or other approaches—are similar whether kidney cancer is hereditary or sporadic. However, hereditary cases often involve multiple tumors or tumors in both kidneys, which may influence whether your doctor recommends kidney-sparing surgery or other approaches to preserve kidney function. Discuss treatment options with your oncologist based on your specific diagnosis.